Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 219,937,499 papers from all fields of science
Search
Sign In
Create Free Account
AA 673
Known as:
AA-673
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
amlexanox
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Pharmacodynamics of Amlexanox (AA-673) in normal and anaphylactic rat conjunctiva and its effect on histamine concentration.
G. Rankov
,
K. Sasaki
,
M. Fukuda
Ophthalmic Research
1990
Corpus ID: 3281719
The pharmacodynamics of Amlexanox (AA-673), an azoxanthone derivative recently developed as an ocular anti-allergic drug, were…
Expand
1989
1989
[Inhibitory effect of amlexanox (AA-673) on the immunological and non-immunological release of histamine or leukotrienes].
S. Kohno
,
T. Shimizu
,
+7 authors
S. Hitomi
Arerugi = [Allergy]
1989
Corpus ID: 7644761
The effect of amlexanox on the non-immunological or immunological release of histamine or leukotrienes (LTs) from passively…
Expand
1989
1989
[Inhibitory effect of AA-673 eye drops on ocular provocation for Japanese cedar pollinosis].
Y. Sakuma
,
H. Mita
Arerugi = [Allergy]
1989
Corpus ID: 103703
The inhibitory effect of 0.25% AA-673 eye drops on histamine release in tears was examined by an ocular provocation test with…
Expand
1989
1989
[Influences of anti-allergic drugs on superoxide generation from the hypoxanthine-xanthine oxidase system or polymorphonuclear leukocytes].
T. Yoshikawa
,
Y. Naito
,
+6 authors
M. Kondo
Arerugi = [Allergy]
1989
Corpus ID: 37334893
The influences of anti-allergic drugs on superoxide generation from the hypoxanthine-xanthine oxidase system or polymorphonuclear…
Expand
1988
1988
Clinical effect of AA-673 tablets in allergic rhinitis.
T. Enomoto
,
H. Nakanishi
,
T. Samukawa
,
K. Sakaguchi
1988
Corpus ID: 76019308
Twenty patients with perennial allergic rhinitis were treated with AA-673 tablets for a mean period of 66 days.Based on the final…
Expand
Highly Cited
1987
Highly Cited
1987
Mechanism of action of an antiallergic agent, amlexanox (AA-673), in inhibiting histamine release from mast cells. Acceleration of cAMP generation and inhibition of phosphodiesterase.
H. Makino
,
T. Saijo
,
Y. Ashida
,
H. Kuriki
,
Y. Maki
International Archives of Allergy and Applied…
1987
Corpus ID: 26284898
Amlexanox markedly inhibits histamine release from rat mast cells. To clarify the mechanism of this inhibition, we investigated…
Expand
1987
1987
Clinical effect of AA-673 nasal spray in allergic rhinitis.
T. Enomoto
,
H. Nakanishi
,
D. Iwahashi
1987
Corpus ID: 76486528
Twenty patients with perennial allergic rhinitis were treated with AA-673 nasal spray for a mean period of 45 days. The global…
Expand
1987
1987
Clinical effect of AA-673 nasal spray in nasal allergy.
J. Watarai
,
H. Ohtake
,
S. Kai
,
K. Uesugi
,
H. Iwasawa
,
I. Takeyama
1987
Corpus ID: 76385309
AA-673 nasal spray (2.7 mg in six doses a day) was administered to 17 patients with nasal allergy in all seasons for 4…
Expand
1985
1985
Inhibition by amoxanox (AA-673) of the immunologically, leukotriene D4- or platelet-activating factor-stimulated bronchoconstriction in guinea pigs and rats.
T. Saijo
,
H. Kuriki
,
Y. Ashida
,
H. Makino
,
Y. Maki
International Archives of Allergy and Applied…
1985
Corpus ID: 1814467
We studied the effects of amoxanox (AA-673) on allergic asthma and spasmogen-induced bronchoconstriction in guinea pigs and rats…
Expand
Highly Cited
1985
Highly Cited
1985
Synthesis of the metabolites and degradation products of 2-amino-7-isopropyl-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3- carboxylic acid (Amoxanox).
K. Ukawa
,
T. Ishiguro
,
H. Kuriki
,
A. Nohara
Chemical and pharmaceutical bulletin
1985
Corpus ID: 27170564
The metabolites and degradation products of 2-amino-7-isopropyl-5-oxo-5H-[1] benzopyrano-[2, 3-b] pyridine-3-carboxylic acid…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required